Search

everythinglearnresearchcommunity

for

Search:↓

Proper care and understanding of skin diseases in pregnant women are crucial for their health and recovery.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Some birth control pills have a higher risk of blood clots than others.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Testosterone may both worsen and protect against COVID-19 effects in men.